PHARM N180 - Final Review.
PHARM N180 - Final Review/PHARM N180 - Final Review. Oral Hypoglycemics Sulfonylureas: Glipizine (Glucotrol) Action: Promotes the release of insulin from the pancreas Risk: Risk of hypoglycemia in clients with renal, hepatic or adrenal disorders. Usually caused by taking too much medication or not eating enough food. Give 30 mins before morning meal Meglitinides:
Geschreven voor
- Instelling
- West Coast University
- Vak
- PHARM N180
Documentinformatie
- Geüpload op
- 23 januari 2021
- Aantal pagina's
- 45
- Geschreven in
- 2020/2021
- Type
- Tentamen (uitwerkingen)
- Bevat
- Vragen en antwoorden
Onderwerpen
-
pharm n180 final review